Literature DB >> 7361751

Is ABH nonsecretor status a risk factor for obstructive lung disease?

B H Cohen, W B Bias, G A Chase, E L Diamond, C G Graves, D A Levy, H Menkes, M B Meyer, S Permutt, M S Tockman.   

Abstract

In a multidisciplinary study of risk factors for chronic obstructive pulmonary disease (COPD), a significantly more impairment of forced expiration was observed in ABH nonsecretors than in ABH secretors among 1017 white adults. (ABH refers to the "A" and "B" antigens of the ABO blood group system and "H", the heterogenetic substance which is found in persons of all ABO types including type "O".) Nonsecretors had significantly lower mean values of forced expiratory volume in one second as a percentage of forced vital capacity (FEV1/FVC%) and a significantly larger proportion of them had aberrant values, defined as FEV1/FVC% less than 68. These differences remained when mean values or rates of aberrancy were adjusted for other factors reported to alter risk of airway obstruction. In view of the known COPD-peptic ulcer and nonsecretor-duodenal ulcer associations, these findings suggest that the ability to secrete ABH antigens into secretions of the respiratory and gastrointestinal tract may have a protective effect on epithelialized organs in general, or on the lung and portions of the gut specifically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361751     DOI: 10.1093/oxfordjournals.aje.a112898

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

3.  Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients.

Authors:  Marcelo A I Barboza; Cinara C Brandão de Mattos; Ana Iara C Ferreira; Paulo R Barja; Newton Santos de Faria Junior; Luís Vicente F de Oliveira; Luiz C de Mattos
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

Review 4.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

5.  Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.

Authors:  Jennifer L Taylor-Cousar; Maimoona A Zariwala; Lauranell H Burch; Rhonda G Pace; Mitchell L Drumm; Hollin Calloway; Haiying Fan; Brent W Weston; Fred A Wright; Michael R Knowles
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

6.  COPD in Asia: where East meets West.

Authors:  Wan C Tan; Tze P Ng
Journal:  Chest       Date:  2008-02       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.